SOPHiA GENETICS SA
SOPH

$209.2 M
Marketcap
$3.20
Share price
Country
$0.07
Change (1 day)
$7.37
Year High
$2.70
Year Low

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

marketcap

Earnings for SOPHiA GENETICS SA (SOPH)

Earnings in 2023 (TTM): $-78,495,000

According to SOPHiA GENETICS SA's latest financial reports the company's current earnings (TTM) are $-78,495,000. The earnings displayed on this page is the company's Pretax Income.

Earnings history of SOPHiA GENETICS SA

Annual Earnings

Year Income Before Tax Net Income
2023 $-78,495,000 $-78,981,000
2022 $-87,585,000 $-87,449,000
2021 $-73,507,000 $-73,675,000
2020 $-41,225,000 $-39,339,000
2019 $-33,629,000 $-33,791,000